M&T Bank Corp Has $107.97 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

M&T Bank Corp decreased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 4.8% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 205,089 shares of the healthcare conglomerate’s stock after selling 10,398 shares during the quarter. M&T Bank Corp’s holdings in UnitedHealth Group were worth $107,973,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in the company. Robbins Farley acquired a new position in shares of UnitedHealth Group in the 3rd quarter worth approximately $25,000. Richelieu Gestion SA bought a new stake in shares of UnitedHealth Group during the fourth quarter worth $26,000. CGC Financial Services LLC lifted its position in UnitedHealth Group by 1,000.0% during the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after buying an additional 50 shares in the last quarter. NewSquare Capital LLC increased its position in UnitedHealth Group by 340.0% in the 3rd quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock valued at $33,000 after acquiring an additional 51 shares in the last quarter. Finally, LFA Lugano Financial Advisors SA lifted its position in shares of UnitedHealth Group by 148.1% during the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after purchasing an additional 40 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The sale was disclosed in a document filed with the SEC, which is available through this link. In related news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is owned by company insiders.

UnitedHealth Group Stock Down 0.1 %

Shares of NYSE UNH traded down $0.52 during midday trading on Friday, reaching $492.45. The company’s stock had a trading volume of 2,487,811 shares, compared to its average volume of 5,130,659. The stock has a market capitalization of $453.09 billion, a price-to-earnings ratio of 30.10, a PEG ratio of 1.43 and a beta of 0.55. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $554.70. The stock has a 50 day simple moving average of $482.32 and a 200-day simple moving average of $512.76. The company has a current ratio of 0.85, a quick ratio of 0.79 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating the consensus estimate of $6.63 by $0.28. The company had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. UnitedHealth Group’s revenue for the quarter was up 8.6% compared to the same quarter last year. During the same quarter last year, the company earned $6.26 EPS. Equities research analysts predict that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were paid a $1.88 dividend. This represents a $7.52 dividend on an annualized basis and a yield of 1.53%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s dividend payout ratio is currently 45.97%.

Analyst Ratings Changes

UNH has been the topic of several research reports. Stephens reaffirmed an “overweight” rating and set a $605.00 price objective on shares of UnitedHealth Group in a report on Thursday, February 8th. Bank of America reiterated a “buy” rating and issued a $675.00 price target on shares of UnitedHealth Group in a report on Thursday, March 7th. TD Cowen reduced their target price on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a research note on Wednesday, April 10th. Cantor Fitzgerald restated an “overweight” rating and issued a $591.00 price objective on shares of UnitedHealth Group in a report on Wednesday, April 10th. Finally, Piper Sandler upped their target price on shares of UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a research report on Wednesday, April 17th. Four research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. According to data from MarketBeat, UnitedHealth Group has an average rating of “Moderate Buy” and a consensus price target of $570.05.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.